Cargando…

The Virus II: Triage and Treatment

Detalles Bibliográficos
Autores principales:	Suresh, Mithun R., Dries, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Air Medical Journal Associates. Published by Elsevier Inc. 2020
Materias:	Critical Care Update
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836356/ https://www.ncbi.nlm.nih.gov/pubmed/33012463 http://dx.doi.org/10.1016/j.amj.2020.06.009

Ejemplares similares

Delta and the Variants
por: Suresh, Mithun R., et al.
Publicado: (2022)

Extracorporeal Membrane Oxygenation and the Virus
por: Dries, David J.
Publicado: (2020)

ARDS From Syndrome to Disease—Treatment Strategies
por: Dries, David J.
Publicado: (2019)

Coronavirus Disease 2019: From Exposure to the Intensive Care Unit—Part 1
por: Dries, David J.
Publicado: (2021)

Coronavirus Disease 2019: From Intensive Care Unit to the Long Haul—Part 2
por: Dries, David J.
Publicado: (2021)

Vaccination
por: Dries, David J.
Publicado: (2022)

Coronavirus Disease 2019: Women and Children
por: Dries, David J.
Publicado: (2021)

Monkeypox
por: Dries, David J.
Publicado: (2022)

Coronavirus Disease 2019 and Stroke
por: Dries, David J., et al.
Publicado: (2021)

The Accuracy of Sepsis Screening Score for Mortality Prediction at Emergency Department Triage
por: Suttapanit, Karn, et al.
Publicado: (2022)

Mitigating Inequities and Saving Lives with ICU Triage during the COVID-19 Pandemic
por: White, Douglas B., et al.
Publicado: (2021)

Comparison of the Mortality Prediction of Different ICU Scoring Systems (APACHE II and III, SAPS II, and SOFA) in Acute Respiratory Distress Syndrome Patients
por: Saleh, Abdelbaset, et al.
Publicado: (2016)

REACTIVATION OF EPSTEIN-BARR VIRUS AND CYTOMEGALOVIRUS INFECTION IN PATIENTS WITH COVID-19
por: ALMAGUER, ANGELICA, et al.
Publicado: (2022)

Update in COVID-19 2020
por: Chotirmall, Sanjay H., et al.
Publicado: (2021)

A REMARKABLE RESPONSE TO ANGIOTENSIN II THERAPY IN SEVERE SARS-COV-2 INFECTION
por: Goetz, Ryan, et al.
Publicado: (2020)

ACUTE MESENTERIC ISCHEMIA IN COVID-19: A DEVASTATING SEQUELAE OF A DEVASTATING DISEASE
por: RABULINSKI, DANIEL J, et al.
Publicado: (2022)

APACHE II SCORE AND MORTALITY RISK PREDICTION IN A US (CALIFORNIAN) COHORT OF CRITICALLY ILL PATIENTS WITH COVID-19
por: CAO, LOUIE, et al.
Publicado: (2021)

DISSEMINATED HERPES ZOSTER VIRUS INFECTION FOLLOWING BARICITINIB IN COVID-19
por: KAUR, GURSHARAN, et al.
Publicado: (2022)

CORONA VIRUS DISEASE-19-INDUCED ACUTE LIVER FAILURE LEADING TO SEVERE METABOLIC ACIDOSIS
por: Sarkar, Sauradeep, et al.
Publicado: (2020)

SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH COVID-19 AND HERPES SIMPLEX VIRUS (HSV): A CASE REPORT
por: VORAKUNTHADA, YUTTIWAT, et al.
Publicado: (2022)

COVID-19 FEARS MAY BE WORSE THAN THE VIRUS: A CASE OF CARDIOGENIC SHOCK SECONDARY TO POST MYOCARDIAL INFARCTION VENTRICULAR SEPTUM RUPTURE
por: Gaballa, Salem, et al.
Publicado: (2020)

CORTICOSTEROID TREATMENT IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA
por: Hong, Gloria, et al.
Publicado: (2020)

Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016
por: Christos, Steve, et al.
Publicado: (2016)

INVESTIGATING HETEROGENEITY OF TREATMENT EFFECT FOR CONVALESCENT PLASMA IN SEVERE COVID-19: SECONDARY ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL
por: SATISH, TEJUS, et al.
Publicado: (2022)

PROLONGED, PROFOUND UNTREATED HYPOXIA IN COVID-19 ARDS WITH REFUSAL OF TREATMENT
por: THOMAS, KALEB, et al.
Publicado: (2021)

LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
por: GUARDIA, CARLOS G, et al.
Publicado: (2022)

Long-term Survival of Critically Ill Patients Stratified According to Pandemic Triage Categories: A Retrospective Cohort Study
por: Darvall, Jai N., et al.
Publicado: (2021)

Acute hypoxaemic respiratory failure after treatment with lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal: long-term outcomes from the REST randomised trial
por: Boyle, Andrew J, et al.
Publicado: (2023)

CHARACTERISTICS, TREATMENTS, AND OUTCOMES OF COVID-19-INFECTED PATIENTS ADMITTED TO THE ICU OF A TERTIARY CARE CENTER IN LANSING, MICHIGAN
por: Raziq, Fazal, et al.
Publicado: (2020)

OOPS, I CLOTTED AGAIN! A CASE OF RECURRENT VTE AND POTENTIAL DRUG-DRUG INTERACTIONS IN TREATMENT OF COVID-19
por: SANTONE, DANIEL, et al.
Publicado: (2021)

OLD MEDICINE FOR NEW PROBLEMS: POTENTIAL ROLE OF A NOVEL TREATMENT USING NEBULIZED HEPARIN IN COVID-19 ARDS
por: DOUEN, AARON, et al.
Publicado: (2021)

Emergency Department-based Intensive Care Unit Use Peaks Near Emergency Department Shift Turnover
por: Haas, Nathan L., et al.
Publicado: (2020)

A Retrospective Analysis of Clinical Manifestations, Management and Outcome of Acute Respiratory Distress Syndrome Associated with Coronavirus Disease-2019 Infection in Children
por: Sarkar, Mihir, et al.
Publicado: (2022)

Randomised Controlled Trial Assessing Head Down Deep Breathing Method Versus Modified Valsalva Manoeuvre for Treatment of Supraventricular Tachycardia in the Emergency Department
por: Lim, Hoon Chin, et al.
Publicado: (2021)

Effect of anti-podoplanin antibody administration during lipopolysaccharide-induced lung injury in mice
por: Lax, Sian, et al.
Publicado: (2017)

MUC5AC and a Glycosylated Variant of MUC5B Alter Mucin Composition in Children With Acute Asthma
por: Welsh, Kathryn G., et al.
Publicado: (2017)

Psychological Outcomes following a nurse-led Preventative Psychological Intervention for critically ill patients (POPPI): protocol for a cluster-randomised clinical trial of a complex intervention
por: Richards-Belle, Alvin, et al.
Publicado: (2018)

Lower versus higher oxygenation targets in critically ill patients with severe hypoxaemia: secondary Bayesian analysis to explore heterogeneous treatment effects in the Handling Oxygenation Targets in the Intensive Care Unit (HOT-ICU) trial
por: Klitgaard, Thomas L., et al.
Publicado: (2022)

Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: a randomised clinical trial
por: Shimabukuro, David W, et al.
Publicado: (2017)

TOCILIZUMAB IN COVID-19: EAST-AFRICAN EXPERIENCE
por: SHAH, R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3dmbrtdpj6h8a88u913a2l09fv